GO:0047975 guanosine phosphorylase activity

Guanosine phosphorylase activity (GO:0047975) is a molecular function that catalyzes the reversible conversion of guanosine and inorganic phosphate into guanine and alpha-D-ribose 1-phosphate. This reaction is central to purine salvage, allowing cells to recycle guanosine rather than degrade it completely. The term is defined in QuickGO as catalysis of the reaction: guanosine + phosphate = alpha-D-ribose 1-phosphate + guanine. Researchers study this activity because it sits at the intersection of nucleotide homeostasis, mitochondrial DNA precursor supply, and drug metabolism [2,6]. The enzyme activity is not always identical to other purine phosphorylases. Early biochemical work distinguished adenosine phosphorylase from inosine-guanosine phosphorylase in Sarcoma 180 cells and rat liver, showing that guanosine cleavage can be catalyzed by separate or overlapping enzyme systems depending on the tissue. This distinction matters for interpreting inhibitor studies and for designing selective assays. In mice lacking purine nucleoside phosphorylase, a secondary loss of deoxyguanosine kinase activity was observed, indicating that guanosine and deoxyguanosine metabolism are tightly connected to mitochondrial nucleotide pools. More recent work has linked guanosine salvage to telomere length regulation. Metabolic constraint of human telomere length by nucleotide salvage efficiency suggests that the flux through guanosine phosphorylase and related salvage enzymes can influence how telomeres are maintained. In parallel, 8-aminoguanine and 8-aminopurines have emerged as pharmacological tools that act on purine metabolism and renal excretory function, highlighting the therapeutic potential of targeting this pathway [4,7]. Classic studies also show that phosphorylase activity and guanosine cyclic 3',5'-monophosphate levels can be modulated by drugs such as hydralazine and verapamil in smooth muscle.

Guanosine phosphorylase activity (GO:0047975) is the catalytic activity that breaks the N-glycosidic bond of guanosine in the presence of phosphate, producing guanine and alpha-D-ribose 1-phosphate. It is a phosphorolysis reaction, meaning phosphate is used to cleave the nucleoside rather than water. The reaction is reversible, so the same activity can also synthesize guanosine from guanine and alpha-D-ribose 1-phosphate. This function belongs to the molecular_function ontology and is synonymous with guanosine:phosphate alpha-D-ribosyltransferase activity and guanosine:phosphate D-ribosyltransferase activity.

Guanosine phosphorylase activity is important because it controls the balance between guanosine salvage and degradation, which affects guanine nucleotide pools, mitochondrial DNA precursor supply, and cellular responses to stress [2,6]. Defects or pharmacological inhibition of this activity can alter deoxyguanosine kinase function and purine homeostasis, with consequences for lymphoproliferative and mitochondrial disorders. The activity is also a target of interest for cardiovascular and renal therapeutics, as 8-aminoguanine and related purines modulate renal excretory function and blood pressure [4,7]. In addition, classic studies show that phosphorylase activity can be pharmacologically dissociated from cyclic GMP responses, making it a useful node for understanding drug action in smooth muscle.

The genes and proteins below are directly or indirectly connected to guanosine phosphorylase activity, purine salvage, and guanosine metabolism based on the cited literature.

Guanosine phosphorylase activity is regulated at multiple levels. In purine nucleoside phosphorylase deficient mice, secondary loss of deoxyguanosine kinase activity indicates that the pathway is subject to metabolic feedback and enzyme stability changes. Nucleotide salvage efficiency, which depends on transporters and salvage enzymes, constrains telomere length and therefore reflects a regulated balance between synthesis and degradation. Pharmacological agents such as hydralazine and verapamil can alter phosphorylase activity and cyclic GMP levels in smooth muscle, showing that the activity is responsive to drug-induced signaling changes. 8-Aminoguanine and 8-aminopurines also modulate renal excretory function, suggesting that purine-based compounds can regulate this pathway in vivo [4,7].

Purine nucleoside phosphorylase deficiency leads to accumulation of guanosine and deoxyguanosine, and in a mouse model this was accompanied by secondary loss of deoxyguanosine kinase activity. This connects guanosine phosphorylase activity to mitochondrial DNA precursor imbalance, which can affect tissues with high mitochondrial demand. The finding is relevant to immunodeficiency and mitochondrial disorders linked to purine metabolism.

Nucleotide salvage efficiency, which includes guanosine phosphorylase activity, can metabolically constrain human telomere length. When salvage is inefficient, altered nucleotide pools may affect telomerase activity and telomere maintenance, with implications for aging and cancer. This makes GO:0047975 relevant to studies of genome stability and proliferative capacity.

8-Aminoguanine and 8-aminopurines act on renal excretory function and blood pressure, and they are being developed as purine-based therapeutics [4,7]. These compounds intersect with guanosine metabolism, suggesting that modulating guanosine phosphorylase activity could influence sodium handling and vascular tone. This area is an active direction for cardiovascular drug discovery [4,7].

In guinea-pig taenia coli, hydralazine and verapamil altered phosphorylase activity and guanosine cyclic 3',5'-monophosphate levels. This classic study shows that phosphorylase activity can be pharmacologically dissociated from cyclic GMP responses, which is important for understanding drug mechanisms in smooth muscle. It also highlights the need to measure guanosine phosphorylase activity separately from cGMP when interpreting drug effects.

Direct measurement of guanosine phosphorylase activity uses guanosine and phosphate as substrates and detects guanine or alpha-D-ribose 1-phosphate formation. Classic studies distinguished this activity from adenosine phosphorylase and inosine-guanosine phosphorylase in Sarcoma 180 cells and rat liver, so assays must include specific controls and inhibitors. Coupled spectrophotometric or HPLC-based methods are typically used to quantify product formation.

Stable isotope tracing and nucleotide pool measurements can quantify flux through guanosine salvage. In PNP-deficient mice, secondary loss of deoxyguanosine kinase activity was detected by enzyme assays, showing the value of combining activity measurements with metabolite profiling. Telomere length studies also used nucleotide salvage efficiency as a metabolic readout.

8-Aminoguanine and 8-aminopurines are used to probe renal excretory function and blood pressure, and they can be tested against guanosine phosphorylase activity in vitro [4,7]. Hydralazine and verapamil have been used to modulate phosphorylase activity and cyclic GMP levels in guinea-pig taenia coli, providing a framework for drug-response studies.

Knockout and knock-in models of PNP, DGUOK, and TERT are used to test causality between guanosine phosphorylase activity and cellular phenotypes [2,6]. CRISPR-based editing allows precise introduction of patient variants and tagged alleles for localization and interaction studies. These models are essential for separating direct effects of the activity from secondary metabolic changes.

Researchers studying guanosine phosphorylase activity-related genes often need to determine whether a candidate gene is causally involved in purine salvage, mitochondrial nucleotide balance, or telomere maintenance. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with publication-ready precision.

Guanosine phosphorylase activity (GO:0047975) is a central purine salvage function that converts guanosine and phosphate into guanine and alpha-D-ribose 1-phosphate. Its connections to deoxyguanosine kinase, mitochondrial nucleotide pools, telomere maintenance, and cardiovascular pharmacology make it a high-value target for basic and translational research [2,4,6,7]. Careful biochemical separation from related phosphorylases and the use of CRISPR models will be essential for defining its precise roles in health and disease [3,8].